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David P. Foley, Rein Melkert, Victor A. Umans, Peter P. de Jaegere, Patrick
W. Serruys Thoraxcentre, Erasmus University, Rotterdam, Netherlands
Left anterior descending (LAD) coronary artery location is reported to be
associated with increased propensity to restenosis after intervention. This
study, in 3736 patients, investigates whether this finding is equally applicable
to intervention with balloon angioplasty (BA, n = 3797 lesions), directional
atherectomy (DCA, n = 200 lesions), Palmaz-Schatz stent implantation (PS,
n ~ 229 lesions) and excimer laser angioplasty (ELCA, n = 116 lesions). Au-
tomated core laboratory quantitative analysis (OCA) was performed in mul-
tiple matched angiographic projections pre and post intervention and at 6
month follow up (overall QCA follow up 93%). Multiple linear regression
analysis was employed to determine whether LAD lesion location was asso-
ciated with greater propensity to luminal renarrowing, independently of le-
sion severity pre, procedural luminal increase and reference vessel diameter.
Because of the large variation in vessel size, lumen renarrowing was mea-
sured as relative luminal loss (minimal luminal diameter (MLD) post-follow
up/reference diameter pre) and angiographic outcome as relative lumen at
follow up (MLD at follow up/reference diameter pre). In multivariate analysis
applied to the entire patient population, LAD location was independently as-
sociated with greater relative loss and smaller lumen at follow up (p = 0.007).
However, application of the model to each patient group separately, revealed
analogous findings for the DCA (p = 0.003) and BA (p = 0.03) groups, but no
significant association between LAD location and late angiographic results
was evident in the PS (p = 0.18) or ELCA (p = 0.55) groups. Retrospective
exclusion of totally occluded lesions at baseline and/or at follow up from the
analysis did not appreciable alter these findings.
Conclusion: LAD lesions were independently associated with less
favourable late angiographic results after balloon angioplasty or directional
atherectomy, whereas late results after Palmaz-Schatz stent implantation or
excimer laser angioplasty did not vary with lesion location. In contrast with
previous reports, these findings suggest a differential influence of lesion lo-
cation on late interventional results, depending on the device used. Accord-
inglyfurther investigation will be required for clarification of this association.
(OR = 2.31, P < 0.05) failure. Although no ELCA effect was noted for late clin-
ical outcome (p = 0.56), a trend toward more ELCA-related events was seen
in TLR (RR = 1.43; P = 0.06). In conclusion: In lesion subsets suitable for
treatment with either device, ELCA-treated patients had: 1) lower Proc-S: 2)
more acute complications; and 3) a trend toward more frequent TLR than
RA-treated patients.
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Influence of Epicardial Lesion Location on Late
Luminal Renarrowing and Angiographic Outcome
After Successful Balloon Angioplasty, Directional
Atherectomy, Stent Implantation and Excimer Laser
Angioplasty
PSS DCA Balloon P
Lesion success (%) 117(95.9) 102 (944) 920 (95.3) 0.87
MLD post (mm) 2.87 ± 0.67 2.84 ± 0.77 2.20 ± 0.96 0.0001
In hospital death (%) 1 (0.9) 0(0.0) 410.5) 0.63
O-Wave MI (%) 2(1.8) 1(1.0) 15 (1.8) 0.85
CABG{%) 5(4.3) 3(2.9) 30(3.5) 0.84
6 months follow-up
PTCA(%) 31 (35) 30 (31) 247 (31) 0.74
CABG(%) 19 (22) 21 (22) 141 (19) 058
Recurrent angina (%) 34(37) 34(34) 340 (42) 0.25
Death (%) 918.5) 4 (39) 37 (4.3) 0.14
Both Palmaz-Schatz stents (PSS) and directional atherectomy (DCA) are re-
ported to be suitable for treating restenotic lesions and claim to decrease
subsequent restenosis. The purpose of this study was to compare in hos-
pital outcome and follow-up (FU) of these two technologies with balloon
angioplasty. Records of 1087 patients with restenosis that underwent elec-
tive (PSS) implantation (116 patients, 122 lesions). DCA (103 patients, 108
lesions), balloon angioplasty in 868 patients, 965 lesions) from January 1988
to March 1994 were reviewed. Mean follow-up was 1.22 ± 0.73 years.
Balloon Angioplasty, Palmaz-Schatz Stent, and
Directional Coronary Atherectomy for Restenotic
Lesions: Retrospective Comparison In a Single
Center
Ron Waksman, William S. Weintraub, Ziyad MB. Ghazzal, John S. Douglas Jr,
Yannan Shen, Spencer B. King III. Emory University School of Medicine, Atlanta, GA
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None of the comparisons were significantly different.
Conclusion: Excimer Laser Angioplasty compared to Balloon Angioplasty
in long coronary lesions yields similar results with respect to longterm clinical
and angiographic outcome.
None of the comparisons were significantly different.
Conclusion: Excimer Laser Angioplasty compared to Balloon Angioplasty
in functional and total coronary occlusion yields similar results with respect
to longterm clinical and angiographic outcome.
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1782-21 Longterm Outcome of Excimer Laser Angioplasty
Versus Balloon Angloplasty in Functional and Total
Coronary Occlusions
Yolande E.A. Appelman, Jacques J. Koolen, Pim J. de Feyter, Sipke Strikwerda,
George K. David, Ken Redekop, Eline v. SWijndregt, Patrick W. Serruys, Jan
G. Tijssen, Jan J. Piek, AMRO study group. The Netherlands
From September 1991 until November 1993 we randomized 103 patients
with functional and total coronary occlusions to Excimer Laser Coronary An-
gioplasty (ELCA, n = 49) or Balloon Angioplasty (BA, n = 54) as part of a
multi-center trial (AMRa) comparing ELCA versus BA in type B or C-Iesions.
We report on the longterm clinical and angiographic outcome of this sub-
group. Procedural success (PS) was defined as <50% residual stenosis at the
end of the procedure. Clinical endpoints were: death (D), myocardial infarc-
tion (MI), coronary bypass surgery (CABG) or repeat angioplasty (re-PTCA) of
the randomized segment within 6 months follow-up. Angiographic endpoint
was the net gain (NG) in minimal lumen diameter at six months follow-up
relative to the pre-procedural baseline determined by a computer-assisted
automated edge detection algorithm (CAAS II). Functional status (FS) at six
months was graded according to the Canadian Cardiovascular Society clas-
sification.
Results: Baseline patient characteristics were similar in both groups. ELCA
was followed by BA in all patients. Re-occlusion of the treated segment dur-
ing 6 months follow-up was 33% in the ELCA group versus 23% in the BA
group (not significant).
1782-31 Rotational Atherectomy vs. Excimer Laser
Angioplasty: A Multi-variable Analysis of Early and
Late Procedural Outcome
Gaston R. Dussaillant, Jeffrey J. Popma, Augusto D. Pichard, Lowell F. Satler,
Kenneth M. Kent, Ya Chien Chuang, Theresa A. Bucher, Benjamin Kleiber,
Anand Desai, Martin B. Leon Washington Hospital Center. Washington, DC
Rotational atherectomy (RA) and excimer laser angioplasty (ELCA) are com-
monly used in lesions unsuitable for balloon angioplasty, but few compara-
tive outcome studies have been performed using these devices in matched
subsets. To address this issue, we reviewed the clinical course of 696 pa-
tients undergoing RA or ELCA in lesions suitable for either technique. Vein
grafts, long (e::20 mm), heavily calcified, thrombus-containing lesions, and to-
tal occlusions were excluded. Angiographic «50% final stenosis), procedu-
ral (proc-S) «50% stenosis and no in-hospital complications [death, Q-wave
myocardial infarction QWMI or CABGI and clinical (Proc-S without rePTCA
<14 days) success, and late events (death, QWMI, target lesion revascu-
larization [TLR, CABG or repeat PTCA)) were recorded for 12 months af-
ter the procedure. Multivariate logistic regression analysis was performed
to evaluate the ELCA effect, accounting for disparities in clinical (unstable
angina, diabetes, multivessel disease) and angiographic (AHA/ACC classifi-
cation, restenosis, length, calcium, eccentricity, angulation, irregularity, and
pre-%DS) variables. ELCA remained an independent predictor for angio-
graphic (OR'" 3.72, P < 0.0051, procedural (OR = 2.96, P < 0.01), and clinical
t p < 005, ttp < 0.01, ttt p < 0.001
